Kaplan–Meier survival analysis revealed that increased SLC3A2 expression was significantly associated with shorter overall survival (OS) (p < 0.0001) in patients with AITL (Figure 3T). Here, SLC3A2 is linked to angioimmunoblastic T-cell lymphoma.